Attovia Therapeutics Prices Initial Public Offering at $17 Per Share on Nasdaq

Attovia Therapeutics, Inc. priced its initial public offering of 17,000,000 shares of common stock at $17.00 per share, expecting gross proceeds of $289.0 million. The common stock is set to begin trading on the Nasdaq Global Market under the ticker symbol 'ATTO' on August 5, 2026.